(Q28274872)
Statements
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement (English)
Bengt I Eriksson
Ola E Dahl
Sylvia Haas
Ajay K Kakkar
Eva Muehlhofer
Christoph Dierig
Frank Misselwitz
Peter Kälebo
ODIXa-HIP Study Investigators
20 November 2006
Identifiers
2 references
2 references